KEAP1 and isolated hemihyperplasia: A key finding of this study was the significant suppression of the KEAP1-NFE2L2 pathway identified through QIAGEN IPA, with suppression observed in both IH and SH groups compared to the control group and notably stronger suppression in the IH group.